Five questions to separate proof from hopium before your manager does. One minute. Nothing stored.
Customer · Money · Power · Path · Now
Most federal pipeline dies for one of five reasons, and the seller usually knows which one before the meeting starts. The point of naming them is to stop pretending otherwise.
A requirement you inferred from a good meeting is not a requirement. What you are looking for is the customer describing the problem in their own words, ideally in writing, and deciding something has to change. If the only person who has articulated the need is you, we may be inventing it. Is there pull, or are we pushing?
Federal money has a name: an appropriation, a program line, an O&M budget, a color of money with a fiscal year attached. "They have budget" with no source is the most common thing a seller believes and cannot defend. You can have a requirement, an enthusiastic customer and a contract vehicle, and still no money that can be applied to the buy. The question your manager will ask is who told you, and what is it called.
Understanding the requirement and controlling the acquisition are different jobs, often different people, sometimes different buildings. Sellers mistake access for influence and enthusiasm for authority; a technical evaluator can love you and still not move a dollar. Progress means a program manager, a contracting officer, or a budget holder, somebody who can cause something to happen when it gets difficult.
Every federal purchase arrives through a mechanism: an existing contract, a GWAC or IDIQ, a task order, a set-aside, a recompete, a sole-source justification. If nobody has named the vehicle and the contracting office, the timeline is guesswork, because acquisition lead time is the timeline. Until somebody can describe how a purchase order eventually appears, you have demand rather than a deal.
Agencies are very good at doing nothing for another year. A forcing function is specific: a contract expiring, a product going end of life, a mandate with a date, an incident, or money that expires September 30. "Q4" is not a compelling event, and neither is "my manager wants it this quarter." What gets worse for them if they do nothing?
I've used both, and plenty of versions of both. They're useful when you are working a deal. This is for the moment before that.
Over the years, most questionable deals I've seen eventually broke in one of the five places above. So those are the five questions. They won't tell you how to sell the deal. They'll tell you where the story stops matching the evidence.
BANT gets you close, but its "need" is usually something the seller diagnosed, and its "timeline" is a date in the CRM rather than a reason anything happens. It also leaves the biggest federal question unanswered: how does the government actually buy this? That's what PATH is for.
MEDDIC (or MEDDPICC, depending on who taught it to you) is more sophisticated, and that is exactly why it solves a different problem. It is for developing and managing a complex opportunity. A seller can spend forty-five minutes deciding whether somebody qualifies as an economic buyer. These five are a cross-examination, not a worksheet. They run before that debate is worth having.
MEDDIC helps you work the deal. Kill My Deal helps you decide whether you've earned the right to call it one.
A pipeline review is a manager testing whether the numbers on the board can survive a question. Deals fail the same handful of ways, and a manager who has sat through a few hundred reviews knows every one of them by sight. The difference between a seller who survives the review and one who does not is rarely deal quality. It is whether they walked in already knowing which question they were going to get hit with.
Five questions, asked out loud, do more than a CRM field ever will. Run them on any deal and you get a shared vocabulary instead of an argument: "I'm good on customer and path, I'm yellow on money and power."
The tool at the top of this page is the same five questions with the arithmetic done for you. It stores nothing and sends nothing, which means it can be used in a room where the CRM cannot. The job is the same every week: get the hopium out of the pipeline before the review.
I led Partner Sales Teams at AWS for six years, sold at F5, Red Hat, STEC and Virident, and before that spent 20 years as a Marine. I've been the seller defending the deal, the manager poking holes in it, the partner trying to help, and the guy explaining the forecast one level up.
These days I work with sales leaders in the middle: responsible for the number, responsible for the people, and getting pressure from both directions. This isn't a big consulting firm. It's just me.
Rarely just one of them. Usually a couple at the same time, quietly making each other worse.
The pipeline looks better than it really is. Plenty of opportunities in the CRM, but once you ask about budget, timing and who actually wants the thing, the number gets smaller fast.
The partner likes you, but nothing is happening. Plenty of meetings, maybe a joint deck. Nobody can point to the accounts where the two companies are actually trying to win something together.
The team is busy, but there isn't much rhythm. The forecast call happens. The one-on-ones happen. Nobody is sure what the team should do differently this week to make next quarter better.
The number from above doesn't match what you see below. Leadership has a growth number. Your team has a pipeline. You're the one who has to explain why they disagree without sounding like you've already given up.
A team can be behind plan for a lot of reasons. One seller needs help getting in front of customers. Another is doing fine and wants you to stay out of the way. Someone else thinks the year is already gone. Sometimes the rep is fine and the territory, the comp plan or the pipeline they inherited isn't. The useful part is figuring out which one you're dealing with before you fix the wrong one. That's what the tools on this site do for one deal and one pipeline. It's also most of what I do.
Talk it through. 20 minutes, free. Bring a deal, a pipeline, or a rep you can't figure out. I'll ask a few questions and tell you what I'd look at first. Sometimes the answer is "I wouldn't change much." That's useful too.
Work through one problem. 90 minutes, paid. One issue, properly: a deal, a territory, a partner, a capture plan, a seller. You get a short write-up afterward so there's something to work from.
Run the review with me. Monthly or for a few weeks. I sit in your pipeline reviews, ask the five questions, and stay involved while the team works the answers.
Free, 20 minutes, no pitch. If I don't think I can help, I'll tell you. I also build fedhoo, a federal market research tool.
Same five-question idea, pointed at the other places a quarter goes wrong.
Kill My Pipeline. For managers. 3X is a rule of thumb; your win rate says what you actually need. Target, pipeline, win rate, and the gap.
Kill My Rep. For managers. Before you write them up, find out whether it is the rep, the territory, the comp plan, or the year they have given up on.
Kill My Partner. For partner managers. Is this partner selling with you, or on your slide?
Kill My Territory. For sellers. Can the patch make the number, or are you being asked to grow where nobody could?